Related Experiment Video
Updated: Oct 10, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
The (Still Unknown) Hypothetical Protective Role of COVID-19 Therapy in Bladder Cancer
1Department of Oncological Urology, Istituto Oncologico Veneto, Castelfranco Veneto, 31033 Treviso, Italy.
Abstract:
The COVID-19 pandemic continues to put a strain on the entire world population. The common features of bladder cancer (BCa) and COVID infection have been widely reported and discussion may continue regarding treatment as well. We have highlighted how COVID-19 therapy has many implications with BCa therapy, in particular with potential protective role.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Urinary Tract Infection II: Pathophysiology
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urinary Tract Infection IV: Nursing Management

